美国优化炎症性肠病护理的障碍。
Barriers to optimizing inflammatory bowel disease care in the United States.
作者信息
Spencer Elizabeth A, Abbasi Sadeea, Kayal Maia
机构信息
Division of Pediatric Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Division of Gastroenterology, Cedars-Sinai Santa Monica Gastroenterology, Santa Monica, CA, USA.
出版信息
Therap Adv Gastroenterol. 2023 May 5;16:17562848231169652. doi: 10.1177/17562848231169652. eCollection 2023.
Significant progress in the management and modification of inflammatory bowel disease (IBD) has been made; however, significant barriers to the optimization of IBD care in the United States still exist. The majority of these barriers are constructed by insurance carriers and the integration of market pressures into healthcare decision-making. In this review, we highlight the barriers to IBD care optimization within the context of the US insurance system and review current and proposed solutions.
在炎症性肠病（IBD）的管理和治疗方面已经取得了显著进展；然而，在美国，优化IBD护理仍存在重大障碍。这些障碍大多是由保险公司造成的，以及市场压力融入医疗保健决策过程。在本综述中，我们重点介绍了美国保险系统背景下IBD护理优化的障碍，并回顾了当前和提议的解决方案。
Zotero 插件